L19TNF Clinical Trials

3 actively recruiting trials across 2 locations

Also known as: onfekafusp alfa

Pipeline

Phase 2: 2Phase 1/2: 1

Top Sponsors

Philogen S.p.A.3

Indications

Cancer3
Glioblastoma2
Melanoma Stage III1
Melanoma Stage IV1

Other1 trial

A Study to Evaluate Safety and Efficacy of L19TNF Plus Lomustine in Patients With Glioblastoma at First Progression

Phase 1/2

Chicago, Illinois1 trial

A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrence

Northwestern Memorial Hospital

Phase 2

New York, New York1 trial

Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination with Pembrolizumab, in Unresectable Melanoma Patients

Memorial Sloan Kettering Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.